Biomarkers for Primary Vitreoretinal Lymphoma: Which Test Should I Perform?
Author:
- 21 August 2026
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 133 (10) , 1276-1277
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Diagnostic Accuracy and Complementary Value of Biomarkers for Primary Vitreoretinal LymphomaOphthalmology, 2026
- The Evolving Role of Molecular Diagnostics in PathologyClinics In Laboratory Medicine, 2024
- Meta-analysis. What have we learned?Injury, 2022
- Primary central nervous system lymphoma – ocular variant: an interdisciplinary review on managementSurvey of Ophthalmology, 2021
- The Concept of Minimal Residual Disease in the Treatment and Staging of Vitreoretinal LymphomaRetina, 2020
- CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potentialEuropean Journal of Haematology, 2018
- Primary Vitreoretinal Lymphoma: A Report from an International Primary Central Nervous System Lymphoma Collaborative Group SymposiumThe Oncologist, 2011